Alison L. Hannah's Net Worth
$2.55 Million
Who is Alison L. Hannah?
Alison L. Hannah has an estimated net worth of $2.55 Million. This is based on reported shares across multiple companies, which include NEOGENOMICS INC, RIGEL PHARMACEUTICALS INC, and CytomX Therapeutics, Inc..
SEC CIK
Alison L. Hannah's CIK is 0001645600
Past Insider Trading and Trends
2021 was Alison L. Hannah's most active year for acquiring shares with 8 total transactions. Alison L. Hannah's most active month to acquire stocks was the month of April. 2017 was Alison L. Hannah's most active year for disposing of shares, totalling 3 transactions. Alison L. Hannah's most active month to dispose stocks was the month of July. 2017 saw Alison L. Hannah paying a total of $300,902.22 for 52,556 shares, this is the most they've acquired in one year. In 2019 Alison L. Hannah cashed out on 11,666 shares for a total of $98,111.41, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NEOGENOMICS INC (NEO) Snapshot price: $16.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.55% | 11.34K |
—
|
—
| 118.77K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4
| +16.93% | 15.56K |
—
|
—
| 107.43K |
Jun 10
| |||
Form 4
| +3.47% | 3.08K |
—
|
—
| 91.88K |
Jun 2
| |||
Form 4
| +12.69% | 10K |
$7.27 | $72,700.00 | 88.8K |
Aug 6
| |||
Form 4
| +3.55% | 2.7K |
—
|
—
| 78.8K |
May 28
| |||
Form 4
| +18.11% | 11.67K |
$8.41 | $98,111.41 | 76.1K |
Sep 9
| |||
Form 4
| +5.60% | 3.42K |
—
|
—
| 64.43K |
Jun 6
| |||
Form 4
| +34.24% | 15.56K |
—
|
—
| 61.01K |
Jun 1
| |||
Form 4
| +17.19% | 6.67K |
$6.66 | $44,402.22 | 45.45K |
Aug 9
| |||
Form 4
| +106.48% | 20K |
$9.19 | $183,800.00 | 38.78K |
Jul 27
| |||
Form 4
| +62.47% | 7.22K |
—
|
—
| 18.78K |
May 25 - May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4
| +18.60% | 2.15K |
$7.15 | $15,372.50 | 13.71K |
Apr 20
| |||
Form 4
| +641.03% | 10K |
$6.90 | $69,000.00 | 11.56K |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RIGEL PHARMACEUTICALS INC (RIGL) Snapshot price: $13.32
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.44% | 25K |
—
|
—
| 81.25K |
May 25
| |||
Form 4
| +80.00% | 25K |
—
|
—
| 56.25K |
May 26
| |||
Form 4
| +400.00% | 25K |
—
|
—
| 31.25K |
May 20
| |||
Form 4
|
∞
| 6.25K |
—
|
—
| 6.25K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CytomX Therapeutics, Inc. (CTMX) Snapshot price: $1.2
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.77% | 9.4K |
$1.42 | -$7,965.48 | 31.9K |
Jul 19 - Jul 20
| |||
Form 4
|
∞
| 22.5K |
—
|
—
| 22.5K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||